top of page
Techniques & Outcomes of Portal Vein Embolization with Dr. David Madoff, Dr. Michael Barraza on the BackTable VI Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 660  •  03 Jul 2026

Techniques & Outcomes of Portal Vein Embolization

How is portal vein embolization (PVE) pushing the boundaries of liver tumor resectability, and what does it take to induce hypertrophy without compromising the remnant liver? In this episode of the BackTable Podcast, interventional radiologist Dr. David Madoff of Yale University joins Dr. Michael Barraza to discuss the pathophysiological rationale, technical considerations, and emerging clinical paradigms of performing PVE to augment the future liver remnant (FLR) prior to resection and reduce the risk of postoperative liver failure.

This podcast is supported by

RADPAD® Radiation Protection

Timestamps

00:00 - Introduction
02:14 - IO Practice and Research
07:25 - PVE Indications and Adequate FLR
12:55 - Referrals and Patient Selection
17:27 - PVE vs. Y90 Radiation Lobectomy
22:12 - Liver Venous Deprivation
25:31 - Measuring FLR Function
30:11 - Procedural Planning and Technique
36:36 - Preferred Embolic Agents and Challenges
46:58 - Ipsilateral vs. Contralateral Access
50:52 - Complications, Medications, and Follow-Up
55:45 - Final Thoughts and Closing Remarks

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

The physicians dissect the anatomic and oncologic benchmarks used to select PVE candidates, including FLR volumetric thresholds for normal, steatotic, and cirrhotic livers. Dr. Madoff walks through his procedural technique, detailing catheter maneuvers and embolic administration, emphasizing the importance of evaluating for anatomic variants, and explaining the benefits of using an ipsilateral approach to protect the FLR. The doctors critique ongoing debates in hepatic augmentation, assess the complementary relationship between PVE and Y90 radioembolization, and discuss the outcomes and risks associated with different embolic agents. They stress the importance of patient selection and assessment protocols that go beyond static volumetric measurements to incorporate functional parameters for better prediction of regenerative kinetics and clinical outcomes. The episode concludes with a review of postprocedural follow-up and potential complications, highlighting the importance of considering pathophysiologic dynamics of both the tumor and the anticipated liver remnant to ensure successful treatment.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page